Main Street Group’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$21.6K Hold
375
0.01% 432
2026
Q1
$22.7K Buy
+375
New +$21.9K 0.01% 418
2025
Q4
Sell
-682
Closed -$30.8K 153
2025
Q3
$30.8K Hold
682
0.01% 320
2025
Q2
$31.6K Sell
682
-24
-3% -$1.18K 0.01% 308
2025
Q1
$43K Sell
706
-1
-0.1% -$58 0.02% 266
2024
Q4
$40K Sell
707
-114
-14% -$6.37K 0.01% 287
2024
Q3
$42.5K Buy
821
+197
+32% +$9.24K 0.02% 282
2024
Q2
$25.8K Sell
624
-426
-41% -$19.1K 0.01% 365
2024
Q1
$56.2K Buy
1,050
+404
+63% +$20.6K 0.02% 262
2023
Q4
$33.2K Buy
+646
New +$33.9K 0.01% 496

Other funds holding BMY

Main Street Group's BMY Position: Q2 2026 in Review

Main Street Group held its Bristol-Myers Squibb (BMY) position steady in Q2 2026 at 375 shares worth $21.6K. The position accounts for 0.01% of the portfolio, ranked #432.

Main Street Group first reported a position in BMY in Q4 2023 and has held it in 10 quarters since. The position peaked at $56.2K in Q1 2024. 796 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Main Street Group held 375 shares of Bristol-Myers Squibb worth $21.6K as of Q2 2026.
  • Main Street Group left its Bristol-Myers Squibb share count unchanged in Q2 2026.
  • Bristol-Myers Squibb made up 0.01% of Main Street Group's portfolio in Q2 2026, its #432 holding.
  • Main Street Group first reported a position in Bristol-Myers Squibb in Q4 2023 and has held it in 10 quarters since.
  • Main Street Group's Bristol-Myers Squibb position peaked at $56.2K in Q1 2024.
  • 796 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Main Street Group's 13F filing for Q2 2026, filed 13 Jul 2026.